• Course Previews
  • New User
  • Returning User
  • News
  • Nov 19th
  • Peering Beyond Registration
  • United for Vision Registration
  • From Diagnosis to Discontent Registration
  • Pressure Points Registration
  • Focus Feud Registration
  • Unveiling Demodex Blepharitis: Comprehensive Diagnosis Registration
  • Effective Strategies for Demodex Blepharitis Registration
  • Meibomian Gland Dysfunction Diagnostic Techniques Registration
  • Management of MGD at Home and in the Office - Registration
  • Thyroid Eye Disease: From Diagnosis to Treatment - Registration
  • Highlights B2 Registration
  • Highlights B3 Registration
  • Highlights B4 Registration
  • Highlights C1 Registration
  • Highlights C2 Registration
  • Highlights C3 Registration
  • Highlights C4 Registration
  • The Role of Tear Osmolarity Registration
  • Understanding Neurotrophic Keratitis Registration
  • Eyelid margin Health Consensus Supplement
  • Advancements in Sjogren's Syndrome Registration
  • Case Study: Managing Meibomian Gland Dysfunction - Registration
  • Case Study: Managing Demodex Blepharitis - Registration
  • Case Study: Managing Neurotrophic Keratitis - Registration
  • Case Study: Managing Ocular Surface Disease - Registration
  • Who Wants to be an Eye Care Millionaire? The Intrepid Edition - On Demand
  • On Demand Video - Understanding Demodex blepharitis and Meibomia
  • Podcast - Understanding Demodex blepharitis and Meibomian Gland
  • On Demand Video - Diagnosis and Screening for Early-Stage Demode
  • On Demand Video - A Diagnostic-Based Decision Tree for MGD and D
  • Podcast - A Diagnostic-Based Decision Tree for MGD and Db Treatm
  • Podcast - Diagnosis and Screening for Early-Stage Demodex Blepha
  • On Demand Video - Innovative Treatments for Demodex blepharitis
  • Podcast - Innovative Treatments for Demodex blepharitis and MGD:
    • Thyroid Eye Disease: From Diagnosis to Treatment

    This course on Thyroid Eye Disease (TED) offers comprehensive insights into diagnosing TED, including understanding its prevalence, impact, and the key signs and symptoms associated with ocular pathologies, as well as a detailed examination process. It further delves into the treatment modalities, focusing on the role of IGF-1R in TED's pathogenesis and the use of teprotumumab, while also distinguishing TED from ocular surface disease (OSD), and culminates with strategies for effective patient discussions.

    This activity, COPE Activity Number 120866, is accredited by COPE for continuing education for optometrists.
    COPE Course No.: 90122-SD

    Release Date: 03-29-2024
    Expiration Date: 03-28-2025

    Grant Support Statement

    This activity is supported by unrestricted educational grants from Alcon, Horizon Therapeutics, SightSciences, and Tarsus Pharmaceuticals, Inc.

    Faculty

    Marc Bloomenstein

     

    Marc Bloomenstein, OD, FAAO

    Director of Optometric Services
    Director of Dry Eye Center of Excellence
    Schwartz Laser Eye Center
    Scottsdale, AZ

    Doug Devries

    Doug Devries, OD

    Director and Managing Partner
    Director of Optometric Residency Program
    Eye Care Associates of Nevada
    Sparks, NV
    Progress
    (Test) The Fundingsland Group © 2025 All Rights Reserved.